Table 1

SCID-X1 dogs treated with in vivo–injected foamy virus vector

AnimalAge at injectionTiter (I.U./mL)VCM volume (mL)Final dose (I.U.)Survival (days)
X348 13 d.o. 1.4 × 108 1.4 (×2) 4.0 × 108 139 
X349 13 d.o. 1.4 × 108 1.4 (×2) 4.0 × 108 306 
R2152 12 d.o. 3 × 108 1.4 (×2) 8.4 × 108 101 
R2202 1 d.o. 3 × 108 0.7 (×2) 4.2 × 108 330 
R2203 1 d.o. 3 × 108 0.7 (×2) 4.2 × 108 119 
AnimalAge at injectionTiter (I.U./mL)VCM volume (mL)Final dose (I.U.)Survival (days)
X348 13 d.o. 1.4 × 108 1.4 (×2) 4.0 × 108 139 
X349 13 d.o. 1.4 × 108 1.4 (×2) 4.0 × 108 306 
R2152 12 d.o. 3 × 108 1.4 (×2) 8.4 × 108 101 
R2202 1 d.o. 3 × 108 0.7 (×2) 4.2 × 108 330 
R2203 1 d.o. 3 × 108 0.7 (×2) 4.2 × 108 119 

Virus was delivered in 2 fractionated doses, 4 hours apart, at the day of life indicated for each dog. The VCM volume is volume per injection, and the total volume received is multiplied by 2 for fractionated injections.

d.o., days old; I.U., infectious units; VCM, vector-conditioned medium.